Kidney Diseases Completed Phase 1 Trials for Siplizumab (DB06371)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00807794A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft RejectionTreatment